Association and its population heterogeneities between low-density lipoprotein cholesterol and all-cause and cardiovascular mortality: A population-based cohort study

被引:0
|
作者
Lu Jiapeng [1 ]
Zhang Haibo [1 ]
Chen Bowang [1 ]
Yang Yang [1 ]
Cui Jianlan [1 ]
Xu Wei [1 ]
Song Lijuan [1 ]
Yang Hao [1 ]
He Wenyan [1 ]
Zhang Yan [1 ]
Peng Wenyao [1 ]
Li Xi [1 ,2 ,3 ]
机构
[1] National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
[2] Shenzhen Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China
[3] Central China Sub-center of the National Center for Cardiovascular Diseases, Zhengzhou, Henan,
关键词
Low-density lipoprotein cholesterol; Mortality; Association study; Population heterogeneity; Prospective cohort study;
D O I
暂无
中图分类号
R54 [心脏、血管(循环系)疾病];
学科分类号
摘要
Background: The association and its population heterogeneities between low-density lipoprotein cholesterol (LDL-C) and all-cause and cardiovascular mortality remain unknown. We aimed to examine the dose-dependent associations of LDL-C levels with specific types of cardiovascular disease (CVD) mortality and heterogeneities in the associations among different population subgroups.Methods: A total of 2,968,462 participants aged 35-75 years from China Health Evaluation And risk Reduction through nationwide Teamwork (ChinaHEART) (2014-2019) were included. Cox proportional hazard models and Fine-Gray subdistribution hazard models were used to estimate associations between LDL-C categories (<70.0, 70.0-99.9, 100.0-129.9 [reference group], 130.0-159.9, 160.0-189.9, and ≥190.0 mg/dL) and all-cause and cause-specific mortality.Results: During a median follow-up of 3.7 years, 57,391 and 23,241 deaths from all-cause and overall CVD were documented. We observed J-shaped associations between LDL-C and death from all-cause, overall CVD, coronary heart disease (CHD), and ischemic stroke, and an L-shaped association between LDL-C and hemorrhagic stroke (HS) mortality (P for non-linearity <0.001). Compared with the reference group (100.0-129.9 mg/dL), very low LDL-C levels (<70.0 mg/dL) were significantly associated with increased risk of overall CVD (hazard ratio [HR]: 1.10, 95% confidence interval [CI]: 1.06-1.14) and HS mortality (HR: 1.37, 95% CI: 1.29-1.45). Very high LDL-C levels (≥190.0 mg/dL) were associated with increased risk of overall CVD (HR: 1.51, 95% CI: 1.40-1.62) and CHD mortality (HR: 2.08, 95% CI: 1.92-2.24). The stronger associations of very low LDL-C with risk of CVD mortality were observed in individuals with older age, low or normal body mass index, low or moderate 10-year atherosclerotic CVD risk, and those without diagnosed CVD or taking statins. Stronger associations between very high LDL-C levels and all-cause and CVD mortality were observed in younger people.Conclusions: People with very low LDL-C had a higher risk of all-cause, CVD, and HS mortality; those with very high LDL-C had a higher risk of all-cause, CVD, and CHD mortality. On the basis of our findings, comprehensive health assessment is needed to evaluate cardiovascular risk and implement appropriate lipid-lowering therapy for people with very low LDL-C.
引用
收藏
相关论文
共 50 条
  • [21] Thyroid function and risk of all-cause and cardiovascular mortality: a prospective population-based cohort study
    Groothof, Dion
    Flores-Guerrero, Jose L.
    Nolte, Ilja M.
    Bouma, Hjalmar R.
    Gruppen, Eke G.
    Bano, Arjola
    Post, Adrian
    Kootstra-Ros, Jenny E.
    Hak, Eelko
    Bos, Jens H. J.
    de Borst, Martin H.
    Gans, Reinold O. B.
    Links, Thera P.
    Dullaart, Robin P. F.
    Bakker, Stephan J. L.
    ENDOCRINE, 2021, 71 (02) : 385 - 396
  • [22] Associations of urinary phytoestrogens with all-cause and cardiovascular mortality in adults: a population-based cohort study
    Xuan, Chao
    Zhao, Cong
    Zhou, Ting-Ting
    Guo, Jun-Jie
    Pan, Deng
    Wang, Zi-Bo
    He, Guo-Wei
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [23] Thyroid function and risk of all-cause and cardiovascular mortality: a prospective population-based cohort study
    Dion Groothof
    Jose L. Flores-Guerrero
    Ilja M. Nolte
    Hjalmar R. Bouma
    Eke G. Gruppen
    Arjola Bano
    Adrian Post
    Jenny E. Kootstra-Ros
    Eelko Hak
    Jens H. J. Bos
    Martin H. de Borst
    Reinold O. B. Gans
    Thera P. Links
    Robin P. F. Dullaart
    Stephan J. L. Bakker
    Endocrine, 2021, 71 : 385 - 396
  • [24] Association between serum pyridoxal 5′-phosphate levels and all-cause, cardiovascular mortality, and cardiovascular disease in adults: a population-based cohort study
    Xuan, Chao
    Liu, Ru-Hua
    Zhao, Cong
    Li, Jing
    Zhou, Ting-Ting
    Tian, Qing-Wu
    He, Guo-Wei
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2024, 15
  • [25] Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: A population-based study
    Jeppesen, Jorgen
    Hansen, Tine Willum
    Rasmussen, Susanne
    Ibsen, Hans
    Torp-Pedersen, Christian
    ATHEROSCLEROSIS, 2006, 189 (02) : 369 - 374
  • [26] Association Between High-Density Lipoprotein Cholesterol With All-Cause Death and Cardiovascular Events in a Primary Prevention Population
    Pagidipati, Neha J.
    Phelan, Matthew
    Navar, Ann Marie
    Pencina, Michael
    Peterson, Eric
    CIRCULATION, 2017, 136
  • [27] The relationship of low-density lipoprotein cholesterol and all-cause or cardiovascular mortality in patients with type 2 diabetes: a retrospective study
    Chang, Chin-Huan
    Yeh, Shu-Tin
    Ooi, Seng-Wei
    Li, Chung-Yi
    Chen, Hua-Fen
    PEERJ, 2023, 11
  • [28] The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: Population-based cohort study
    Shankar, Anoop
    Mitchell, Paul
    Rochtchina, Elena
    Wang, Jie Jin
    ATHEROSCLEROSIS, 2007, 192 (01) : 177 - 183
  • [29] Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: a population-based longitudinal cohort study
    Palmer, Suetonia C.
    Wong, Germaine
    Iff, Samuel
    Yang, Jean
    Jayaswal, Vivek
    Craig, Jonathan C.
    Rochtchina, Elena
    Mitchell, Paul
    Wang, Jie Jin
    Strippoli, Giovanni F. M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (07) : 1377 - 1384
  • [30] All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study
    Fleming, Kate M.
    Aithal, Guruprasad P.
    Card, Tim R.
    West, Joe
    LIVER INTERNATIONAL, 2012, 32 (01) : 79 - 84